Keith D. Eaton

ORCID: 0000-0001-5025-2001

Also affiliated with Fred Hutch Cancer Center, University of Washington Applied Physics Laboratory

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma”.

Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001009

N/A

0DataRank · unranked

56 citations

Kevin C. Miller, Lina Altameemi, M. Shaaban Ali, Sameh Nassar, Naveen Garg +10 more

MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity

Genes & Development(2020)10.1101/gad.340133.120

N/A

0DataRank · unranked

90 citations

Nan Wu, Huajia Zhang, Xiaoli Liu, Justin P. Norton, Yamini M. Ohol +12 more

Prognostic role of mid-treatment PET/CT and plasma cytokines in patients undergoing chemoradiation for locally advanced non-small cell lung cancer (LA-NSCLC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9040

N/A

0DataRank · unranked

0 citations

Ramesh Rengan, Christina S. Baik, Keith D. Eaton, Bernardo H. L. Goulart, Sylvia Lee +9 more

Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer

Advances in Radiation Oncology(2021)10.1016/j.adro.2021.100857

N/A

0DataRank · unranked

4 citations

Daniel S. Hippe, Hannah Thomas, Balukrishna Sasidharan, Paul D. Lampe, Christina S. Baik +12 more

Prognostic value and peripheral immunologic correlates of early FDG PET response imaging in a phase II trial of risk-adaptive chemoradiation for unresectable non-small cell lung cancer

medRxiv(2021)10.1101/2021.02.22.21251919

N/A

0DataRank · unranked

1 citations

Daniel S. Hippe, Hannah Thomas, Balukrishna Sasidharan, Paul D. Lampe, Christina S. Baik +12 more

Peripheral blood T-cell receptor repertoire profiling of advanced non-small cell lung cancer patients receiving PD-1/PD-L1 treatment.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21004

N/A

0DataRank · unranked

0 citations

Shin‐Heng Chiou, Viswam S. Nair, Renato Martins, Rafael Santana-Dávila, Sylvia Lee +4 more

Long term outcomes in patients with recurrent/metastatic (R/M) salivary gland cancer (SGC) treated with immune checkpoint inhibitors (ICI).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.e18063

N/A

0DataRank · unranked

1 citations

Vicky Wu, Kevin Ng, Jenna Voutsinas, Ariana Dumenigo‐Jimenez, Jonathan R. Fromm +15 more

Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer

medRxiv(2025)10.1101/2025.03.10.25323586

N/A

0DataRank · unranked

0 citations

Christina S. Baik, Joel W. Neal, Fangdi Sun, Rafael Santana-Dávila, Sylvia Lee +13 more